Protective Effect of EPA on Cardiovascular Events

Completed

Phase 4 Results

Summary of Purpose

The purpose of this study was to test the hypothesis that the long-term use of highly (>98%) purified EPA, in addition to HMG-CoA reductase inhibitor (statin), would be more effective than statin alone in preventing cardiovascular events in Japanese patients with hypercholesterolemia.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 November 2015.

1 Nov 1996 3 Oct 2005 Unavailable 1 Nov 2004 1 Oct 2005 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available